During the past decade, Studienzentrum Dr.Beate Schwarz conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Studienzentrum Dr.Beate Schwarz" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Studienzentrum Dr.Beate Schwarz" are "Atopic Dermatitis" (4 trials), "Skin Diseases" (3 trials), "Dermatitis" (1 trials), "Dermatitis, Atopic" (1 trials) and "Eczema" (1 trials). Many other conditions were trialed in "Studienzentrum Dr.Beate Schwarz" in a lesser frequency.

Most popular intervention types in "Studienzentrum Dr.Beate Schwarz" are "Drug" (4 trials), "Biological" (2 trials), "Combination Product" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Lebrikizumab" (2 trials), "Orismilast modified release tablets" (2 trials), "Abrocitinib 200 mg" (1 trials) and "Dupilumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Studienzentrum Dr.Beate Schwarz" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Studienzentrum Dr.Beate Schwarz". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Studienzentrum Dr.Beate Schwarz, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Studienzentrum Dr.Beate Schwarz, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".